1-5 of 5
Ann D. Thor
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Exogenous Thyroid Hormone Is Associated with Shortened Survival and Upregulation of High-Risk Gene Expression Profiles in Steroid Receptor–Positive Breast Cancers

Reema S. Wahdan-Alaswad, Susan M. Edgerton, Hiba Salem, Hyun Min Kim, Aik Choon Tan, Jessica Finlay-Schultz, Elizabeth A. Wellberg, Carol A. Sartorius, Britta M. Jacobsen, Bryan R. Haugen, Bolin Liu, Ann D. Thor
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2021) 27 (2): 585–597.
https://doi.org/10.1158/1078-0432.CCR-20-2647
Published: 19 January 2021
View article titled, Exogenous Thyroid Hormone Is Associated with Shortened Survival and Upregulation of High-Risk Gene Expression Profiles in Steroid Receptor–Positive Breast Cancers
Open the PDF for Exogenous Thyroid Hormone Is Associated with Shortened Survival and Upregulation of High-Risk Gene Expression Profiles in Steroid Receptor–Positive Breast Cancers in another window
Includes: Supplementary data
Journal Articles

Abstract B20: Role of ErbB3 in tumorigenesis and drug resistance in ErbB2-driven breast cancer

Hui Lyu, Jingcao Huang, Susan M. Edgerton, Ann D. Thor, Bolin Liu
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (4_Supplement): B20.
https://doi.org/10.1158/1557-3265.PMS14-B20
Published: 13 February 2015
View article titled, Abstract B20: Role of ErbB3 in tumorigenesis and drug resistance in ErbB2-driven breast cancer
Journal Articles

p53 Expression in Node-Positive Breast Cancer Patients: Results from the Cancer and Leukemia Group B 9344 Trial (159905)

Jonathan F. Lara, Ann D. Thor, Lynn G. Dressler, Gloria Broadwater, Ira J. Bleiweiss, Susan Edgerton, David Cowan, Lori J. Goldstein, Silvana Martino, James N. Ingle, I. Craig Henderson, Larry Norton, Eric P. Winer, Clifford A. Hudis, Matthew J. Ellis, Donald A. Berry, Daniel F. Hayes, for the Cancer and Leukemia Group B
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (15): 5170–5178.
https://doi.org/10.1158/1078-0432.CCR-11-0484
Published: 31 July 2011
View article titled, p53 Expression in Node-Positive Breast Cancer Patients: Results from the Cancer and Leukemia Group B 9344 Trial (159905)
Open the PDF for p53 Expression in Node-Positive Breast Cancer Patients: Results from the Cancer and Leukemia Group B 9344 Trial (159905) in another window
Journal Articles

Gelsolin as a Negative Prognostic Factor and Effector of Motility in erbB-2-positive Epidermal Growth Factor Receptor-positive Breast Cancers

Ann D. Thor, Susan M. Edgerton, Shuqing Liu, Dan H. Moore, II, David J. Kwiatkowski
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (8): 2415–2424.
Published: 01 August 2001
View article titled, Gelsolin as a Negative Prognostic Factor and Effector of Motility in erbB-2-positive Epidermal Growth Factor Receptor-positive Breast Cancers
Open the PDF for Gelsolin as a Negative Prognostic Factor and Effector of Motility in erbB-2-positive Epidermal Growth Factor Receptor-positive Breast Cancers in another window
Journal Articles

Measures of Cell Turnover (Proliferation and Apoptosis) and Their Association with Survival in Breast Cancer

Shuqing Liu, Susan M. Edgerton, Dan H. Moore, II, Ann D. Thor
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (6): 1716–1723.
Published: 01 June 2001
View article titled, Measures of Cell Turnover (Proliferation and Apoptosis) and Their Association with Survival in Breast Cancer
Open the PDF for Measures of Cell Turnover (Proliferation and Apoptosis) and Their Association with Survival in Breast Cancer in another window